Immune-based therapy for COVID-19

A Esmaeilzadeh, D Jafari, S Tahmasebi, R Elahi… - … Disease-COVID-19, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel zoonotic virus
identified as the cause of coronavirus disease 2019 (COVID-19) that has crossed species …
被引用次数：22 相关文章
[PDF] researchgate.net

[PDF][PDF] Immune-Based Therapy for COVID-19

A Esmaeilzadeh, D Jafari, S Tahmasebi… - … Disease-COVID-19 - researchgate.net
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel zoonotic virus
identified as the cause of coronavirus disease 2019 (COVID-19) that has crossed species …

Immune-Based Therapy for COVID-19

A Esmaeilzadeh, D Jafari… - Advances in …, 2021 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel zoonotic virus
identified as the cause of coronavirus disease 2019 (COVID-19) that has crossed species …

Immune-Based Therapy for COVID-19

A Esmaeilzadeh, D Jafari, S Tahmasebi… - … Disease-COVID-19, 2021 - books.google.com
Abstract against the virus, antibody-based immunotherapies of COVID-19 include injection
of convalescent plasma from recovered patients, high-dose intravenous immunoglobulins …

Immune-Based Therapy for COVID-19.

A Esmaeilzadeh, D Jafari, S Tahmasebi… - … Medicine and Biology, 2021 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel zoonotic virus
identified as the cause of coronavirus disease 2019 (COVID-19) that has crossed species …

Immune-Based Therapy for COVID-19

A Esmaeilzadeh, D Jafari, S Tahmasebi, R Elahi… - … Disease-COVID-19 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel zoonotic virus
identified as the cause of coronavirus disease 2019 (COVID-19) that has crossed species …